drugset
drugset / Trial / NCT02419677

Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for Colorectal Cancer Liver Metastases

NCT02419677 ↗

Phase 2/3 Completed 60 enrolled The First People's Hospital of Changzhou
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether combining of radiofrequency ablation (RFA) and cytokine-induced killer cells (CIK) transfusion can prolong survival of patients with colorectal cancer liver metastases (CRCLM).

Timeline

Start
2010-01
Primary completion
2014-12
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Subject CIK cells Cell therapy — Intravenous

Indications

colorectal cancer